期刊文献+

SF-36量表评估心脏瓣膜病患者术后生活质量的研究进展 被引量:13

Progress in Evaluating Quality of Life in Postoperative Patients with Valvular Heart Disease Using SF-36 Health Survey
原文传递
导出
摘要 生活质量评估是从患者主观感受角度评估患者病情,近半个世纪来,逐渐成为临床评价治疗效果的一项重要指标。生活质量评估量表众多,SF-36健康调查简表(the 36-Item Short Form Health Survey,SF-36)是目前应用最广泛的量表。近年来,SF-36量表逐渐应用于探索影响心脏瓣膜病患者术后生活质量的危险因素,为临床医生提供了更多的术前评估方法,提高了手术治疗效果。但目前SF-36用于评估心脏瓣膜病患者生活质量刚刚起步,受样本量、随访时间、地域、文化等因素的影响,结论有一定分歧。为此,我们对目前用SF-36量表评估心脏瓣膜病患者术后生活质量的研究进展进行综述,以更好地应用SF-36量表。 Quality of life (QOL) refers to an individual's perception and subjective evaluation of their health and well-being, and has become an important index to evaluate the outcomes of clinical treatment in the last past decades. There are a large number of different instruments to evaluate QOL, and the 36-Item Short Form Health Survey (SF-36) is currently one of the most widely used instruments. In recent years, SF-36 has been used to evaluate QOL of valvular heart disease patients to investigate the risk factors those influence their postoperative QOL, provide more preoperative evaluation tools for clinical physicians, and improve postoperative outcomes of patients with valvular heart disease. However, it is now just the beginning to use SF-36 to examine QOL of valvular heart disease patients. Because of significant differences in sample size, follow-up period, country and culture, current research has some controversial results. This review focuses on the progress in evaluating QOL in postoperative patients with valvular heart disease using SF-36.
作者 颜涛 徐志云
出处 《中国胸心血管外科临床杂志》 CAS 2012年第4期419-422,共4页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词 生活质量 心脏瓣膜病 危险因素 SF-36量表 Quality of life Valvular heart disease Risk factor SF-36
  • 相关文献

参考文献27

  • 1徐志云.心血管手术风险预测研究与现状[J].中国胸心血管外科临床杂志,2011,18(3):187-188. 被引量:11
  • 2Aaronson NK, Acquadro C, Alonso J, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res, 1992, 1 (5) : 349-351.
  • 3Power M, Harper A, Bullinger M. The World Health Organization WHOQOL-100: tests of the universality of quality of life in 15 dif- ferent cultural groups worldwide. Health Psychol, 1999, 18 (5): 495-505.
  • 4Ware JE, Snow KK, Kosinski M, et al. Chief editor. SF-36 Health Survey: Manual and Interpretation Guide. Boston: New England Medical Center the Health Institute, 1993. 1-2.
  • 5Ware JE Jr, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol, 1998, 51 (11): 1159-1165.
  • 6Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidcmiol, 1998, 51 ( 11 ) : 903-912.
  • 7McCarthy MJ Jr, Shroyer AL, Sethi GK, et al. Self-report measures for assessing treatment outcomes in cardiac surgery patients. Med Care, 1995, 33 ( l0 Suppl) : OS76-85.
  • 8Ware JE Jr, Sherboume CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 1992, 30(6): 473-483.
  • 9Sundt TM, Bailey MS, Moon MR, et al. Quality of life after aortic valve replacement at the age of > 80 years. Circulation, 2000, 102 (19 Suppl 3): Ⅲ70-74.
  • 10Goldsmith IR, Lip GY, Patel RL. A prospective study of changes in the quality of life of patients following mitral valve repair and re- placement. Eur J Cardiothorac Surg, 2001,20 (5) : 949-955.

二级参考文献42

  • 1马谋超,汪培庄.心理学的方法学探讨——心理的模糊性及模糊统计试验评注[J].心理学报,1985,17(2):177-186. 被引量:19
  • 2Elayda MA, Hall R J, Reul RM, et al. Aortic valve replacement in patients 80 years and older: operative risks and long-term results [ J]. Circulation, 1993, 88(part 2): 11-6.
  • 3Notzold A, Huppe M, Schmidtke C, et al. Quality of life in aortic valve replacement: pulmonary autografts versus mechanical prostheses[J]. JAm Coil Cardiol, 2001, 37: 1963-6.
  • 4MeHomey CA, Ware JE Jr, Lu JFR, et al. The MOS 36 Item Short Form Health Survey (SF 36): tests of data quality, scaling assumptions, and reliability across diverse patient groups [J]. Med Care, 1994, 32: 40-66.
  • 5Ware JE, Sherboume CD. The MOS SF-36 Short Form Health Survey (SF-36). Conceptual framework and item selection [J ]. Med Care, 1992, 30: 473-81.
  • 6Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention[J].J Am Coil Cardiol, 2000, 36:1131-41.
  • 7Westaby S, Huysmans H, David TE. Stentless aortic bioprostheses: Compelling data from the second international symposium [J].Ann Thorac Surg, 1998, 65: 235-40.
  • 8David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: a case match study [J]. J Thorac Cardiovasc Surg, 1998, 116: 236-41.
  • 9Blais C, Dumesnil JG, Baillot R, et al. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement[J]. Circulation, 2003, 108: 983-8.
  • 10Ruel M, Rubens FD, Masters RG, et al. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves[J]. J Thorac Cardiovas Surg, 2004, 127: 149-59.

共引文献2437

同被引文献178

引证文献13

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部